High incidence of classical Kaposi's sarcoma in Iceland and the Faroe Islands
1998

High Incidence of Kaposi's Sarcoma in Iceland and the Faroe Islands

Sample size: 26 publication Evidence: moderate

Author Information

Author(s): H Hjalgrim, H Tulinius, J Dalberg, S Hardarson, M Frisch, M Melbye

Primary Institution: Department of Epidemiology Research, Danish Epidemiology Science Centre, Statens Serum Institut, Copenhagen, Denmark

Hypothesis

What factors contribute to the high incidence of classical Kaposi's sarcoma in Iceland and the Faroe Islands?

Conclusion

The study found surprisingly high incidence rates of classical Kaposi's sarcoma in both Iceland and the Faroe Islands.

Supporting Evidence

  • The incidence rates of Kaposi's sarcoma in Iceland and the Faroe Islands were among the highest ever reported in Caucasian populations.
  • In Iceland, the world standardized incidence rate was 0.4 per 100,000 person-years for men and 0.3 for women.
  • In the Faroe Islands, the rates were 0.6 for men and 0.5 for women.
  • None of the patients were immigrants, suggesting local factors may contribute to the high incidence.

Takeaway

This study looked at how many people got a rare skin cancer called Kaposi's sarcoma in Iceland and the Faroe Islands, and found that a lot more people had it there than in other places.

Methodology

The study involved reviewing cancer registry data and original histological specimens to confirm diagnoses of Kaposi's sarcoma.

Potential Biases

There is a risk of bias due to the small sample size and the specific populations studied.

Limitations

The study is based on a relatively small number of cases, which limits the conclusions that can be drawn.

Participant Demographics

The study included 19 cases in Iceland (9 men, 10 women) and 7 cases in the Faroe Islands (4 men, 3 women).

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication